Subcutaneous Infliximab – the beginning of the era of biobetters in the treatment of immune-mediated inflammatory diseases
Authors:
Michnová K.
Published in:
Gastroent Hepatol 2022; 76(3): 268-271
Category:
Labels
Paediatric gastroenterology Gastroenterology and hepatology SurgeryArticle was published in
Gastroenterology and Hepatology
2022 Issue 3
- Metamizole vs. Tramadol in Postoperative Analgesia
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
- Spasmolytic Effect of Metamizole
- Metamizole in the Treatment of Acute Postoperative Pain
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
Most read in this issue
- Endoscopic therapy of gastroesophageal reflux disease using radiofrequency energy (Stretta procedure) – treatment of the first patients in the Czech Republic
- Gastroscopy – quality standards of the Czech Society of Gastroenterology
- A rare cause of biliary obstruction – a case study
- Prof. Julius Špičák, MD, PhD, jubilant